Want to learn more about menopause, hormone replacement therapy (HRT), estrogen, and breast cancer risk? Why not sit down, pop in some headphones, and listen to this podcast from our partners at…Read More
Over the years, Mirakind has shared research and information about the KRAS-variant and how it can have many health implications – from cancer to autoimmunity to response to hormone replacement therapy. Now,…Read More
Clinical Trial for Patients with the KRAS-variant and Head and Neck Squamous Cell Carcinoma (HNSCC).
Here on MiraKind.org, we’ve already discussed how the KRAS-variant plays a role in breast cancer risk, ovarian cancer risk, effects of HRT in the KRAS-variant patients, and even autoimmunity! Now, we want…Read More
Jenn Roark was only 33 when she was first diagnosed with Invasive Ductal Breast Cancer. She felt a hard spot on her breast, short of a lump, but decided to be safe…Read More
When pathology reports from her lung cancer biopsy showed that 56-year-old Karen Peterson was positive for the KRAS oncogene, she had never heard of the KRAS protein before. Karen and her family…Read More
Q&A & Discusson
Video 2 in our Ask Me Anything Series: Dr. Joanne Weidhaas answers your questions in our Ask Me Anything video series. Have a Question for Dr. Joanne? Submit your Q here…Read More